A focus on the association of Apol1 with kidney disease in children

被引:12
|
作者
Ekulu, Pepe M. [1 ,2 ]
Nkoy, Agathe B. [2 ]
Adebayo, Oyindamola C. [1 ]
Kazadi, Orly K. [2 ]
Aloni, Michel N. [2 ]
Arcolino, Fanny O. [1 ]
Ngiyulu, Rene M. [2 ]
Gini, Jean-Lambert E. [2 ]
Lepira, Francois B. [3 ]
van den Heuvel, Lamberthus P. [1 ,4 ]
Levtchenko, Elena N. [5 ,6 ]
机构
[1] Katholieke Univ Leuven, Dept Dev & Regenerat, Leuven, Belgium
[2] Univ Kinshasa, Div Nephrol, Dept Pediat, Fac Med,Univ Hosp Kinshasa, Kinshasa, DEM REP CONGO
[3] Univ Kinshasa, Div Nephrol, Dept Internal Med, Fac Med,Univ Hosp Kinshasa, Kinshasa, DEM REP CONGO
[4] Radboud Univ Nijmegen, Dept Pediat Nephrol, Med Ctr, Nijmegen, Netherlands
[5] Katholieke Univ Leuven, Dept Pediat Nephrol, Univ Hosp Leuven, Leuven, Belgium
[6] Katholieke Univ Leuven, Dept Dev & Regenerat, Univ Hosp Leuven, Leuven, Belgium
关键词
APOL1; Chronic kidney disease; Children; Genetics; Sickle cell disease; HIV-associated nephropathy; STAGE RENAL-DISEASE; AFRICAN-AMERICAN CHILDREN; RISK VARIANTS; APOLIPOPROTEIN L1; NEPHROPATHY; GENE; GENOTYPE; OUTCOMES; ALLELES; ADULTS;
D O I
10.1007/s00467-020-04553-z
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Individuals of African origin have an increased risk of developing various progressive chronic kidney diseases (CKD). This risk has been attributed to genetic variants (G1, G2) in apolipoprotein-L1 (APOL1) gene. In the pediatric population, especially in children affected by sickle cell disease (SCD), by human immunodeficiency virus (HIV), or with various glomerular diseases, APOL1 risk variants have been associated with the development of hypertension, albuminuria, and more rapid decline of kidney function. The present review focuses on existing APOL1-related epidemiological data in children with CKD. It also includes data from studies addressing racial disparities in CKD, the APOL1-related innate immunity, and the relationship between APOL1 and CKD and pathogenic pathways mediating APOL1-related kidney injury.
引用
收藏
页码:777 / 788
页数:12
相关论文
共 50 条
  • [31] Association of MYH9/APOL1 with chronic kidney disease in a UK population reply
    Cooke, Jessica N.
    Bowden, Donald W.
    Langefeld, Carl D.
    Freedman, Barry I.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (09) : 3660 - 3662
  • [32] Effect of APOL1 disease risk variants on APOL1 gene product
    Haque, Shabirul
    Patil, Gauri
    Mishra, Abheepsa
    Lan, Xiqian
    Popik, Waldemar
    Malhotra, Ashwani
    Skorecki, Karl
    Singhal, Pravin C.
    BIOSCIENCE REPORTS, 2017, 37
  • [33] The Mechanism of Kidney Disease Due to APOL1 Risk Variants
    Pays, Etienne
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2020, 31 (11): : 2502 - 2505
  • [34] APOL1 risk variants drive kidney disease in mice
    Susan J. Allison
    Nature Reviews Nephrology, 2017, 13 : 259 - 259
  • [35] Small Molecule APOL1 Inhibitors Block APOL1 Pore Function and Reduce Proteinuria in an APOL1-Mediated Kidney Disease Mouse Model
    Zimmerman, Brandon
    Dakin, Leslie
    Fortier, Anne
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 419 - 419
  • [36] New Insights into APOL1 and Kidney Disease in African Children and Brazilians Living With End-Stage Kidney Disease
    Ross, Michael J.
    KIDNEY INTERNATIONAL REPORTS, 2019, 4 (07): : 908 - 910
  • [37] The Expanding Role of APOL1 Risk in Chronic Kidney Disease and Cardiovascular Disease
    Estrella, Michelle M.
    Parekh, Rulan S.
    SEMINARS IN NEPHROLOGY, 2017, 37 (06) : 520 - 529
  • [38] Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants
    Egbuna, Ogo
    Zimmerman, Brandon
    Manos, George
    Fortier, Anne
    Chirieac, Madalina C.
    Dakin, Leslie A.
    Friedman, David J.
    Bramham, Kate
    Campbell, Kirk
    Knebelmann, Bertrand
    Barisoni, Laura
    Falk, Ronald J.
    Gipson, Debbie S.
    Lipkowitz, Michael S.
    Ojo, Akinlolu
    Bunnage, Mark E.
    Pollak, Martin R.
    Altshuler, David
    Chertow, Glenn M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (11): : 969 - 979
  • [39] APOL1 Kidney Disease Discovery to Targeted Therapy in 10 Years
    Sedor, John R.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 19 (01): : 126 - 128
  • [40] APOL1 variants and kidney disease in people of recent African ancestry
    Giulio Genovese
    David J. Friedman
    Martin R. Pollak
    Nature Reviews Nephrology, 2013, 9 : 240 - 244